Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Acinetobacter baumannii treatment strategies: a review of therapeutic challenges and considerations

Antimicrobial Agents and Chemotherapy(2025)10.1128/aac.01063-24Source: DataRank Database

Acinetobacter baumannii treatment strategies: a review of therapeutic challenges and considerations is a research paper published in Antimicrobial Agents and Chemotherapy (2025). On theSindex it has a DataRank of 0. It has been cited 29 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access29 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 11.05)OA: hybridTopics (42)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Christopher Garzia ORCID,Anne‐Catrin Uhlemann ORCID,Christine J. Kubin ORCID

Live enrichment

PubMed:40631987 PMC:PMC12326985 OpenAlex:https://openalex.org/W4412116670

National Institutes of Health

Grant: K24 AI183182

National Institutes of Health

Grant: 1R01AI183668

National Institutes of Health

Grant: U54 DK104309

NIAID NIH HHS

Grant: R01 AI183668

FWCI

11.05

Citation Percentile

1.0%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1128/aac.01063-24

publisherhttps://doi.org/10.1128/aac.01063-24

publisherhttps://journals.asm.org/doi/pdf/10.1128/aac.01063-24

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40631987

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12326985

Fields of Study

Antibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyPneumonia and Respiratory InfectionsAcinetobacter baumanniiHumansAnti-Bacterial AgentsAcinetobacter InfectionsCarbapenemsSulbactamDrug Resistance, Multiple, BacterialDrug Therapy, CombinationBacteremiaMicrobial Sensitivity TestsTigecycline

MeSH Terms

TigecyclineAcinetobacter InfectionsAnti-Bacterial AgentsDrug Therapy, CombinationHumansMicrobial Sensitivity TestsSulbactamCarbapenemsBacteremiaDrug Resistance, Multiple, BacterialAcinetobacter baumannii

Keywords

Acinetobacter baumanniiTigecyclineIntensive care medicineMedicineAntibiotic resistanceColistinCombination therapySulbactamAntibioticsBiologyPseudomonas aeruginosaMicrobiologyInternal medicineImipenemAcinetobacterPharmacokineticsAntimicrobial Chemotherapy

Sustainable Development Goals

SDG 0: Good health and well-being